EDT — Spectral Medical Share News
0.000.00%
Last trade - 00:00- CA$324.10m
- CA$348.98m
- CA$2.44m
Brief: Spectral Medical Provides Tigris Trial Update
Brief: Spectral Medical Announces Opening Of Tigris Clinical Trial Site At The Mayo Clinic
Brief: Spectral Medical Provides Tigris Trial Update
Brief: Spectral Medical Provides Board Update
Brief: Spectral Medical Inc. Closes C$6.1 Million 'Bought Deal' Convertible Note Financing
Brief: Spectral Medical Announces Tigris Clinical Trial Update
Brief: Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., To Its Board Of Directors
Brief: Spectral Medical Provides Update On Continued Favorable Tigris Clinical Trial Enrollment
Brief: Spectral Medical Provides Update On Favorable Tigris Clinical Trial Enrollment
Brief: Spectral Medical Announces First Quarter Results
Brief: Spectral Medical Announces Positive Results Of Euphas-2 Clinical Trial Evaluating Pmx In Critically Ill Endotoxemic Septic Shock Patients
Brief: Spectral Medical Announces Fourth Quarter And Fiscal 2022 Results And Provides Corporate Update
Brief: Spectral Medical Announces The Opening Of Two Additional Tigris Clinical Trial Sites
Brief: Spectral Medical Provides Update On Tigris Clinical Trial And Other Business Developments
Brief: Spectral Medical Announces Strategic Joint Venture With Infomed To Accelerate Commercialization Of Dialysis Devices
Brief: Spectral Medical Announces Third Quarter Results
Brief: Spectral Medical Announces Pricing Of Previously Announced Offering
Brief: Spectral Medical Announces Proposed Public Offering Of Units
Brief: Spectral Medical announces FDA approval to add up to 10 additional tigris clinical trial sites